Negative Pressure Wound Therapy Devices Market to Reach $3.34 Bn, by 2027, at 5.7% CAGR: Allied Market Research

News provided by

Jun 03, 2020, 10:30 ET

PORTLAND, Oregon, June 3, 2020 /PRNewswire/ -- Allied Market Research published a report, titled, "Negative Pressure Wound Therapy Devices Market by Product (Conventional NPWT Devices and Single Use NPWT Devices), Application (Chronic Wounds and Acute Wounds), and End User (Hospitals & Clinics, Ambulatory Surgery Centers (ASCs), and Home Care Settings): Global Opportunity Analysis and Industry Forecast, 2020–2027." According to the report, the global negative pressure wound therapy devices industry was estimated at $2.14 billion in 2020, and is expected to hit $3.34 billion by 2027, registering a CAGR of 5.7% from 2020 to 2027.

Drivers, restraints, and opportunities-

Rapidly aging population, increase in incidences of chronic conditions, technological advancements in NPWT devices to deal with complex wounds, and surge in awareness to reduce healthcare costs drive the growth of the global negative pressure wound therapy devices market. On the other hand, complications related to NPWT impede the growth to some extent. However, increased focus toward advanced treatment protocols and significant unmet needs in wound care are expected to create multiple opportunities in the industry.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/434

COVID-19 scenario-

The outbreak of the pandemic has made people more cautious about several health measures. And, growing prevalence of chronic diseases such as diabetes & obesity and mounting use of single use devices have boosted the negative pressure wound therapy devices market.
Still, disruptions in the supply chain are likely to hamper the market to certain extent.
However, the industry is quite likely to benefit from the growing awareness about healthcare.

The conventional NPWT devices segment to lead the trail by 2027-

Based on product, the conventional NPWT devices segment contributed to more than three-fourths of the global negative pressure wound therapy devices market share in 2019, and is expected to lead the trail by 2027, owing to their use in management of wounds with large volume of exudate. On the other hand, the single use NPWT devices would grow at the fastest CAGR of 7.1% throughout the forecast period. This is due to the range of benefits they offer.

The chronic wounds segment to maintain the lion's share-

Based on wound type, the chronic wounds segment accounted for nearly two-thirds of the global negative pressure wound therapy devices market revenue in 2019, and is projected to retain its dominance during the study period. The same segment is also anticipated to register the fastest CAGR of 6.1% from 2020 to 2027, owing to surge in prevalence of medical conditions that lead to chronic wounds.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/434

North America to rule the roost in terms of revenue-

Based on region, North America garnered the major share in 2019, holding around two-fifths of the global negative pressure wound therapy devices market. This is due to the presence of key players in the region, easy availability of NPWT devices, surge in prevalence of medical conditions leading to acute and chronic wounds, and rise in launch of new and advanced products. Simultaneously, the Asia-Pacific region would portray the fastest CAGR of 7.9% till 2027. This is attributed to factors such as surge in adoption of NPWT devices and rise in healthcare expenditure.

Key players in the industry-

ATMOS MedizinTechnik GmbH & Co. KG
Talley group Ltd.
Cardinal Health.
Smith & Nephew Plc.
DeRoyal Industries, Inc.
Devon International Group,
3M (Acelity L.P. Inc.,)
Investor AB (Mölnlycke Health Care AB)
ConvaTec Group Plc.
Olle Larsson Holding AG (Medela AG), and

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter

Get more information: https://www.alliedmarketresearch.com/library-access

Anti-Viral Therapies Market Global Opportunity Analysis and Industry Forecast 2019-2026

Asia-Pacific IVF Services Market Analysis and Industry Forecast 2019–2028

Direct Fed Microbial Market Global Opportunity Analysis and Industry Forecast, 2019–2026

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): 1-800-792-5285, 1-503-894-6022, 1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research